A synthetic suicide riboswitch for the high-throughput screening of metabolite production in Saccharomyces cerevisiae

Metabolic Engineering

Volumn 28, Issue , 2015, Pages 143-150

  Lee, Sang Woo ^a   Oh, Min Kyu ^a  

^a Korea University   (South Korea)

Author keywords

Evolutionary engineering; GlmS ribozyme; Random mutagenesis; Riboswitch

Indexed keywords

AMINO ACIDS; BIOMOLECULES; ESCHERICHIA COLI; GLUCOSAMINE; METABOLITES; PHOSPHATASES; YEAST;

EVOLUTIONARY ENGINEERING; GLUCOSAMINE 6-PHOSPHATE; GRAM-POSITIVE BACTERIUM; HIGH THROUGHPUT SCREENING; NACETYL GLUCOSAMINE (GLCNAC); RANDOM MUTAGENESIS; RIBOSWITCHES; RIBOZYMES;

THROUGHPUT;

CYTOSINE DEAMINASE; FLUCYTOSINE; GLMS ENZYME; GLUCOSAMINE DERIVATIVE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HALOACID DEHALOGENASE LIKE PHOSPHATASE; N ACETYLGLUCOSAMINE; PHOSPHATASE; RIBOZYME; RNA; UNCLASSIFIED DRUG; BACTERIAL RNA; ESCHERICHIA COLI PROTEIN; GFA1 PROTEIN, S CEREVISIAE; RIBOSWITCH; SACCHAROMYCES CEREVISIAE PROTEIN;

3' UNTRANSLATED REGION; ALLOSTERISM; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; FUNGUS GROWTH; HIGH THROUGHPUT SCREENING; INTRACELLULAR SPACE; METABOLITE; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; RIBOSWITCH; SACCHAROMYCES CEREVISIAE; SUICIDE GENE; SUICIDE RIBOSWITCH; BIOSYNTHESIS; GENETICS; METABOLISM; SUICIDE TRANSGENE;

ESCHERICHIA COLI; POSIBACTERIA; SACCHAROMYCES CEREVISIAE;

CYTOSINE DEAMINASE; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENES, TRANSGENIC, SUICIDE; GLUTAMINE-FRUCTOSE-6-PHOSPHATE TRANSAMINASE (ISOMERIZING); RIBOSWITCH; RNA, BACTERIAL; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 84921476371     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2015.01.004     Document Type: Article

References (65)

1. Abbas C.A., Sibirny A.A. Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol. Mol. Biol. Rev. 2011, 75:321-360.
2. Alper H., Moxley J., Nevoigt E., Fink G.R., Stephanopoulos G. Engineering yeast transcription machinery for improved ethanol tolerance and production. Science 2006, 314:1565-1568.
3. Araki M., Okuno Y., Hara Y., Sugiura Y. Allosteric regulation of a ribozyme activity through ligand-induced conformational change. Nucleic Acids Res. 1998, 26:3379-3384.
4. Barrick J.E., Corbino K.A., Winkler W.C., Nahvi A., Mandal M., Collins J., Lee M., Roth A., Sudarsan N., Jona I., Wickiser J.K., Breaker R.R. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control. Proc. Natl. Acad. Sci. USA 2004, 101:6421-6426.
5. Binder S., Schendzielorz G., Stabler N., Krumbach K., Hoffmann K., Bott M., Eggeling L. A high-throughput approach to identify genomic variants of bacterial metabolite producers at the single-cell level. Genome Biol. 2012, 13:R40.
6. Brachmann C.B., Davies A., Cost G.J., Caputo E., Li J., Hieter P., Boeke J.D. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 1998, 14:115-132.
7. Chang A.L., Wolf J.J., Smolke C.D. Synthetic RNA switches as a tool for temporal and spatial control over gene expression. Curr. Opin. Biotechnol. 2012, 23:679-688.
8. Chou K.C. Molecular therapeutic target for type-2 diabetes. J. Proteome Res. 2004, 3:1284-1288.
9. Cochrane J.C., Lipchock S.V., Strobel S.A. Structural investigation of the GlmS ribozyme bound to its catalytic cofactor. Chem. Biol. 2007, 14:97-105.
10. Corbino K.A., Barrick J.E., Lim J., Welz R., Tucker B.J., Puskarz I., Mandal M., Rudnick N.D., Breaker R.R. Evidence for a second class of S-adenosylmethionine riboswitches and other regulatory RNA motifs in alpha-proteobacteria. Genome Biol. 2005, 6:R70.
11. Deng M.D., Severson D.K., Grund A.D., Wassink S.L., Burlingame R.P., Berry A., Running J.A., Kunesh C.A., Song L., Jerrell T.A., Rosson R.A. Metabolic engineering of Escherichia coli for industrial production of glucosamine and N-acetylglucosamine. Metab. Eng. 2005, 7:201-214.
12. Desai S.K., Gallivan J.P. Genetic screens and selections for small molecules based on a synthetic riboswitch that activates protein translation. J. Am. Chem. Soc. 2004, 126:13247-13254.
13. Dietrich J.A., McKee A.E., Keasling J.D. High-throughput metabolic engineering: advances in small-molecule screening and selection. Annu. Rev. Biochem. 2010, 79:563-590.
14. Elbein S.C., Zheng H., Jia Y., Chu W., Cooper J.J., Hale T., Zhang Z. Molecular screening of the human glutamine-fructose-6-phosphate amidotransferase 1 (GFPT1) gene and association studies with diabetes and diabetic nephropathy. Mol. Genet. Metab. 2004, 82:321-328.
15. Gonzalez B., Francois J., Renaud M. A rapid and reliable method for metabolite extraction in yeast using boiling buffered ethanol. Yeast 1997, 13:1347-1355.
16. Heidelberger C., Ansfield F.J. Experimental and clinical use of fluorinated pyrimidines in cancer chemotherapy. Cancer Res. 1963, 23:1226.
17. Heidelberger C., Danenberg P.V., Moran R.G. Fluorinated pyrimidines and their nucleosides. Adv. Enzymol. Relat. Areas Mol. Biol. 1983, 54:57-119.
18. Horowitz J., Chargaff E. Massive incorporation of 5-fluorouracil into a bacterial ribonucleic acid. Nature 1959, 184:1213-1215.
19. Jacobsen H., Klenow H., Overgaard-Hansen K. The N-terminal amino-acid sequences of DNA polymerase I from Escherichia coli and of the large and the small fragments obtained by a limited proteolysis. Eur. J. Biochem. 1974, 45:623-627.
20. Kikuchi H., Tsuiki S. Glucosaminephosphate synthase of human liver. Biochim. Biophys. Acta 1976, 422:241-246.
21. Klein D.J., Ferre-D'Amare A.R. Structural basis of glmS ribozyme activation by glucosamine-6-phosphate. Science 2006, 313:1752-1756.
22. Kuznetsova E., Proudfoot M., Gonzalez C.F., Brown G., Omelchenko M.V., Borozan I., Carmel L., Wolf Y.I., Mori H., Savchenko A.V., Arrowsmith C.H., Koonin E.V., Edwards A.M., Yakunin A.F. Genome-wide analysis of substrate specificities of the Escherichia coli haloacid dehalogenase-like phosphatase family. J. Biol. Chem. 2006, 281:36149-36161.
23. Lee S.W., Kim E., Kim J.S., Oh M.K. Artificial transcription regulator as a tool for improvement of cellular property in Saccharomyces cerevisiae. Chem. Eng. Sci.. 2013, 103:42-49.
24. Levine M.N., Bramwell V.H., Pritchard K.I., Norris B.D., Shepherd L.E., Abu-Zahra H., Findlay B., Warr D., Bowman D., Myles J., Arnold A., Vandenberg T., MacKenzie R., Robert J., Ottaway J., Burnell M., Williams C.K., Tu D. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 1998, 16:2651-2658.
25. Lim J., Grove B.C., Roth A., Breaker R.R. Characteristics of ligand recognition by a glmS self-cleaving ribozyme. Angew. Chem. 2006, 45:6689-6693.
26. Longley D.B., Harkin D.P., Johnston P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
27. Lou C., Stanton B., Chen Y.J., Munsky B., Voigt C.A. Ribozyme-based insulator parts buffer synthetic circuits from genetic context. Nat. Biotechnol. 2012, 30:1137-1142.
28. Martick M., Horan L.H., Noller H.F., Scott W.G. A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA. Nature 2008, 454:899-902.
29. Metzger R., Leichman C.G., Danenberg K.D., Danenberg P.V., Lenz H.J., Hayashi K., Groshen S., Salonga D., Cohen H., Laine L., Crookes P., Silberman H., Baranda J., Konda B., Leichman L. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J. Clin. Oncol. 1998, 16:309-316.
30. Michener J.K., Smolke C.D. High-throughput enzyme evolution in Saccharomyces cerevisiae using a synthetic RNA switch. Metab. Eng. 2012, 14:306-316.
31. Morris S.M. The genetic toxicology of 5-fluoropyrimidines and 5-chlorouracil. Mutat. Res. 1993, 297:39-51.
32. Mumberg D., Muller R., Funk M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 1995, 156:119-122.
33. Neuenschwander M., Butz M., Heintz C., Kast P., Hilvert D. A simple selection strategy for evolving highly efficient enzymes. Nat. Biotechnol. 2007, 25:1145-1147.
34. Nomura Y., Yokobayashi Y. Reengineering a natural riboswitch by dual genetic selection. J. Am. Chem. Soc. 2007, 129:13814-13815.
35. Nudler E., Mironov A.S. The riboswitch control of bacterial metabolism. Trends Biochem. Sci. 2004, 29:11-17.
36. Pelletier J., Sonenberg N. Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic messenger-rna reduces translational efficiency. Cell 1985, 40:515-526.
37. Pfleger B.F., Pitera D.J., Newman J.D., Martin V.J., Keasling J.D. Microbial sensors for small molecules: development of a mevalonate biosensor. Metab. Eng. 2007, 9:30-38.
38. Prommana P., Uthaipibull C., Wongsombat C., Kamchonwongpaisan S., Yuthavong Y., Knuepfer E., Holder A.A., Shaw P.J. Inducible knockdown of Plasmodium gene expression using the glmS ribozyme. PLoS One 2013, 8:e73783.
39. Raczynska J., Olchowy J., Konariev P.V., Svergun D.I., Milewski S., Rypniewski W. The crystal and solution studies of glucosamine-6-phosphate synthase from Candida albicans. J. Mol. Biol. 2007, 372:672-688.
40. Ramberg E.S., Ishaq M., Rulf S., Moeller B., Horowitz J. Inhibition of transfer RNA function by replacement of uridine and uridine-derived nucleosides with 5-fluorouridine. Biochemistry 1978, 17:3978-3985.
41. Roth A., Breaker R.R. The structural and functional diversity of metabolite-binding riboswitches. Annu. Rev. Biochem. 2009, 78:305-334.
42. Santos C.N., Stephanopoulos G. Melanin-based high-throughput screen for l-tyrosine production in Escherichia coli. Appl. Environ. Microbiol. 2008, 74:1190-1197.
43. Shikhman A.R., Amiel D., Dlima D., Hwang S.B., Hu C., Xu A., Hashimoto S., Kobayashi K., Sasho T., Lotz M.K. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann. Rheum. Dis. 2005, 64:89-94.
44. Shikhman A.R., Kuhn K., Alaaeddine N., Lotz M. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J. Immunol. 2001, 166:5155-5160.
45. Shirota Y., Stoehlmacher J., Brabender J., Xiong Y.P., Uetake H., Danenberg K.D., Groshen S., Tsao-Wei D.D., Danenberg P.V., Lenz H.J. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol. 2001, 19:4298-4304.
46. Sikdar M.S.I., Kim J.S. Expression of a natural fusion gene for uracil phosphoribosyltransferase and uridine kinase from rice shows growth retardation by 5-fluorouridine or 5-fluorouracil in Escherichia coli. Afr. J. Biotechnol. 2010, 9:1295-1303.
47. Slusarczyk A.L., Lin A., Weiss R. Foundations for the design and implementation of synthetic genetic circuits. Nat. Rev. Genet. 2012, 13:406-420.
48. Smith R.J., Milewski S., Brown A.J., Gooday G.W. Isolation and characterization of the GFA1 gene encoding the glutamine:fructose-6-phosphate amidotransferase of Candida albicans. J. Bacteriol. 1996, 178:2320-2327.
49. Soukup G.A., Breaker R.R. Engineering precision RNA molecular switches. Proc. Natl. Acad. Sci. USA 1999, 96:3584-3589.
50. Suess B., Fink B., Berens C., Stentz R., Hillen W. A theophylline responsive riboswitch based on helix slipping controls gene expression in vivo. Nucleic Acids Res. 2004, 32:1610-1614.
51. Tang J., Breaker R.R. Rational design of allosteric ribozymes. Chem. Biol. 1997, 4:453-459.
52. Topp S., Gallivan J.P. Guiding bacteria with small molecules and RNA. J. Am. Chem. Soc. 2007, 129:6807-6811.
53. Trinh K.Y., O'Doherty R.M., Anderson P., Lange A.J., Newgard C.B. Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J. Biol. Chem. 1998, 273:31615-31620.
54. Trujillo J.L., Gan J.C. Purification and some kinetic-properties of bovine thyroid-gland l-glutamine - d-fructose-6-phosphate amidotransferase. Int. J. Biochem. 1974, 5:515-523.
55. Umeyama T., Okada S., Ito T. Synthetic gene circuit-mediated monitoring of endogenous metabolites: identification of GAL11 as a novel multicopy enhancer of s-adenosylmethionine level in yeast. ACS Synth. Biol. 2013, 2:425-430.
56. Vinkenborg J.L., Karnowski N., Famulok M. Aptamers for allosteric regulation. Nat. Chem. Biol. 2011, 7:519-527.
57. Wang D.Y., Lai B.H., Sen D. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes. J. Mol. Biol. 2002, 318:33-43.
58. Watson P.Y., Fedor M.J. The glmS riboswitch integrates signals from activating and inhibitory metabolites in vivo. Nat. Struct. Mol. Biol. 2011, 18:359-363.
59. Weber W., Link N., Fussenegger M. A genetic redox sensor for mammalian cells. Metab. Eng. 2006, 8:273-280.
60. Win M.N., Smolke C.D. A modular and extensible RNA-based gene-regulatory platform for engineering cellular function. Proc. Natl. Acad. Sci. USA 2007, 104:14283-14288.
61. Winkler W.C., Breaker R.R. Regulation of bacterial gene expression by riboswitches. Annu. Rev. Microbiol. 2005, 59:487-517.
62. Winkler W.C., Nahvi A., Roth A., Collins J.A., Breaker R.R. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 2004, 428:281-286.
63. Yang J., Seo S.W., Jang S., Shin S.I., Lim C.H., Roh T.Y., Jung G.Y. Synthetic RNA devices to expedite the evolution of metabolite-producing microbes. Nat. Commun. 2013, 4:1413.
64. Yatsyshyn V.Y., Ishchuk O.P., Voronovsky A.Y., Fedorovych D.V., Sibirny A.A. Production of flavin mononucleotide by metabolically engineered yeast Candida famata. Metab. Eng. 2009, 11:163-167.
65. Zimmermann G.R., Wick C.L., Shields T.P., Jenison R.D., Pardi A. Molecular interactions and metal binding in the theophylline-binding core of an RNA aptamer. RNA 2000, 6:659-667.